Basal cell carcinoma (BCC) is the most common malignancy in the United States; however, it has beenrelatively understudied in epidemiologic research. Temporal trends indicate that BCC incidence is increasingoverall, in young adults, and especially in young women. Data from 'early onset' cases support the conceptthat there are at least two different subgroups accounting for BCCs in individuals below the age of 40?agroup with single tumors whose incidence is increasing, presumably due to environmental factors, and agroup with multiple tumors whose incidence is stable and who probably have hereditary predisposition toBCCs. The purpose of this study is to assess genetic and environmental risk factors for early onset BCCsand explore the interaction between these factors. This study is an outgrowth of our previous work showingthat the PTCH gene underlies both hereditary and sporadic BCCs but applies and extends this work at apopulation level, with careful consideration of environmental contributions to the disease incidence.Five hundred cases with early onset BCC and 500 controls with benign skin conditions will be recruited fromthe Yale dermatopathology database for interviews and collection of biological samples. Questionnaire datawill be used to assess potential environmental factors that might be related to the increased incidence,especially artificial tanning, excessive solar radiation exposure, smoking, and obesity. The interactionbetween these environmental variables and genetic variants of MC1R, known to relate to skin cancersusceptibility, will be assessed. Tumors from selected subjects in whom BCC risk appears to be relatedstrongly to a particular environmental exposure will undergo sequencing of the PTCH gene to relate thereported exposure to 'signature mutations' in DNA. Subjects with large numbers of BCCs or particularlyearly age of onset of BCCs will have detailed genetic studies to determine if they have a known hereditarydisorder, and if not, to identify novel BCC predisposition genes.Risk factor data are needed to serve as a basis to guide preventive interventions. For example, strongevidence that tanning bed use is an important etiologic factor in early onset BCC, with supporting evidenceshowing mutational spectra consistent with UVB mutations, could form the basis for stronger legislation toprevent tanning bed use by minors. Alternatively, if smoking or other risk factors are more stronglyassociated, this suggests a different intervention strategy to reduce the disease. Identification of underlyingpredisposition genes may help target efforts at prevention to particular genetic subgroups. Thus, thisetiologic work is highly and immediately translatable into preventive interventions aimed at reducing theincidence of this exceedingly common malignancy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
1P50CA121974-01
Application #
7147297
Study Section
Special Emphasis Panel (ZCA1-GRB-I (M1))
Project Start
2006-06-01
Project End
2011-05-31
Budget Start
2006-06-01
Budget End
2007-06-30
Support Year
1
Fiscal Year
2006
Total Cost
$220,516
Indirect Cost
Name
Yale University
Department
Type
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
06520
Ferrucci, Leah M; Cartmel, Brenda; Clare, Rachel A et al. (2018) Cross-sectional assessment of ultraviolet radiation-related behaviors among young people after a diagnosis of melanoma or basal cell carcinoma. J Am Acad Dermatol 79:149-152
Arbesman, Joshua; Ravichandran, Sairekha; Funchain, Pauline et al. (2018) Melanoma cases demonstrate increased carrier frequency of phenylketonuria/hyperphenylalanemia mutations. Pigment Cell Melanoma Res 31:529-533
Perry, Curtis J; Muñoz-Rojas, Andrés R; Meeth, Katrina M et al. (2018) Myeloid-targeted immunotherapies act in synergy to induce inflammation and antitumor immunity. J Exp Med 215:877-893
Liu, Xiaoni; Zhang, Shang-Min; McGeary, Meaghan K et al. (2018) KDM5B Promotes Drug Resistance by Regulating Melanoma Propagating Cell Subpopulations. Mol Cancer Ther :
Sulkowski, Parker L; Scanlon, Susan E; Oeck, Sebastian et al. (2018) PTEN Regulates Nonhomologous End Joining By Epigenetic Induction of NHEJ1/XLF. Mol Cancer Res 16:1241-1254
Chen, Ling; Azuma, Takeshi; Yu, Weiwei et al. (2018) B7-H1 maintains the polyclonal T cell response by protecting dendritic cells from cytotoxic T lymphocyte destruction. Proc Natl Acad Sci U S A 115:3126-3131
Krauthammer, Michael (2018) Unraveling the etiology of primary malignant melanoma of the esophagus. J Thorac Dis 10:S1074-S1075
Das, Rituparna; Bar, Noffar; Ferreira, Michelle et al. (2018) Early B cell changes predict autoimmunity following combination immune checkpoint blockade. J Clin Invest 128:715-720
Miller, Chad J; Muftuoglu, Yagmur; Turk, Benjamin E (2017) A high throughput assay to identify substrate-selective inhibitors of the ERK protein kinases. Biochem Pharmacol 142:39-45
Kluger, Harriet M; Zito, Christopher R; Turcu, Gabriela et al. (2017) PD-L1 Studies Across Tumor Types, Its Differential Expression and Predictive Value in Patients Treated with Immune Checkpoint Inhibitors. Clin Cancer Res 23:4270-4279

Showing the most recent 10 out of 172 publications